On May 17, 2021, GlaxoSmithKline have backed the drugs Company amid concerns that Elliott Management, is preparing to agitate for a shake-up. Institutional shareholders have contacted Jonathan Symonds, the Company’s chairman, to offer support for the board’s efforts not to become distracted from its current strategy. BlackRock, Dodge & Cox, and Royal London are said to have given support, in a boost for Dame Emma Walmsley.